SHZ:002082
Wanbangde Pharmaceutical Holding Group Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 13:31 UTC
Last close
n/aCNY
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.32Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Growth is the furthest below its sector's middle: 0.04 against 0.50 on the market's range.
- Growth-39.4%4 of 100, below its sector
- Returns on capital-7.9%36 of 100, above its sector
- Marginsn/anot placed
- Price2.5x29 of 100, below its sector
- Safety0.3251 of 100, below its sector
- What it pays out0.8%48 of 100, above its sector
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
Follow one yuan
lens 1 of 9The five stops
5 of 5 read- After what it costs to make1,144,718,400102%
- After running the business-139,337,836-12.5%
- After interest and tax-198,777,200-17.8%
- After what it must reinvest314,329,59328.1%
- Kept after the dividend266,631,09523.9%
Of every unit of sales, 0.24 is still there after the dividend.
Of every unit of sales, 0.24 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales1,117,324,092
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it costs to make1,144,718,400
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After running the business-139,337,836
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After interest and tax-198,777,200
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it must reinvest314,329,593
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Kept after the dividend266,631,095
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY